Biphasic Action of Vigabatrin on Cortical Epileptic After-discharges in Rats

Overview

Journal Naunyn Schmiedebergs Arch Pharmacol

Specialty Pharmacology

Date 2004 Feb 10

PMID 14767635

Citations 1

Authors

Pavel Mares

Romana Slamberova

Affiliations

Soon will be listed here.

Abstract

The time course of the anticonvulsant effect of vigabatrin against cortically induced epileptic after-discharges (ADs) was studied in freely moving rats with implanted electrodes. Adult rats (n=30) were exposed to five stimulation sessions each consisting of six stimulation series at 20-min intervals. The first session was a control one, then two groups of animals (n=10 each) were given vigabatrin (600 or 1,200 mg/kg i.p.), the control animals received physiological saline. Stimulation sessions were repeated 1, 24, 48, and 96 hours after the injection. Control animals exhibited an increased transition from the spike-and-wave type of AD to the second, "limbic" type and an increased intensity of movements accompanying stimulation. ADs in the second and subsequent sessions were, however, shorter than in the first session. Vigabatrin facilitated the transition to the second type of AD 1 h after administration but suppressed this transition as well as decreased the number of stimulations eliciting ADs 48 h later. AD duration and the severity of clonic seizures accompanying spike-and-wave ADs were influenced similarly. The effects of the lower dose of vigabatrin were more marked than those of the higher dose. The biphasic action of vigabatrin in our model might be due either to uneven changes of GABA concentration in different brain structures or to an additional mechanism of action. Our results in a cortical model of seizure demonstrate that the sequence of pro- and anticonvulsant actions of vigabatrin is not restricted to seizures of limbic origin and might represent a general phenomenon.

Citing Articles

Molecular mechanisms of antiseizure drug activity at GABAA receptors.

Greenfield Jr L Seizure. 2013; 22(8):589-600.

PMID: 23683707 PMC: 3766376. DOI: 10.1016/j.seizure.2013.04.015.

References

Schechter P, Tranier Y, Jung M, Bohlen P . Audiogenic seizure protection by elevated brain GABA concentration in mice: effects of gamma-acetylenic gaba and gamma-vinyl GABA, two irreversible GABA-T inhibitors. Eur J Pharmacol. 1977; 45(4):319-28. DOI: 10.1016/0014-2999(77)90270-9. View

Sayin U, Rutecki P, Mellanby J, Sutula T . Gamma-vinyl GABA reduces paired pulse inhibition in the rat dentate gyrus in vivo and in vitro. Epilepsy Res. 2001; 44(2-3):109-17. DOI: 10.1016/s0920-1211(01)00200-5. View

Halonen T, Pitkanen A, Saano V, Riekkinen P . Effects of vigabatrin (gamma-vinyl GABA) on neurotransmission-related amino acids and on GABA and benzodiazepine receptor binding in rats. Epilepsia. 1991; 32(2):242-9. DOI: 10.1111/j.1528-1157.1991.tb05251.x. View

Haugvicova R, Kubova H, Mares P . Does vigabatrin possess an anticonvulsant action against pentylenetetrazol-induced seizures in developing rats?. Physiol Res. 2002; 51(4):363-70. View

Loscher W, Vetter M, Bohme G, Stoltenburg-Didinger G . In vivo effects of anticonvulsant drugs on nerve terminal (synaptosomal) GABA levels in 11 brain regions of the rat. J Neural Transm. 1985; 63(2):157-67. DOI: 10.1007/BF01252615. View

Mutani R, Cantello R, Gianelli M, Bettucci D . Rational basis for the development of new antiepileptic drugs. Epilepsy Res Suppl. 1991; 3:23-8. View

GODDARD G, McIntyre D, Leech C . A permanent change in brain function resulting from daily electrical stimulation. Exp Neurol. 1969; 25(3):295-330. DOI: 10.1016/0014-4886(69)90128-9. View

Loscher W, Honack D, Gramer M . Effect of depth electrode implantation with or without subsequent kindling on GABA turnover in various rat brain regions. Epilepsy Res. 1999; 37(2):95-108. DOI: 10.1016/s0920-1211(99)00038-8. View

Shin C, Rigsbee L, McNamara J . Anti-seizure and anti-epileptogenic effect of gamma-vinyl gamma-aminobutyric acid in amygdaloid kindling. Brain Res. 1986; 398(2):370-4. DOI: 10.1016/0006-8993(86)91498-8. View

10.

Mares P, Haugvicova R, Kubova H . Unequal development of thresholds for various phenomena induced by cortical stimulation in rats. Epilepsy Res. 2002; 49(1):35-43. DOI: 10.1016/s0920-1211(02)00009-8. View

11.

McIntyre D, Rajala J, Edson N . Suppression of amygdala kindling with short interstimulus intervals: effect of norepinephrine depletion. Exp Neurol. 1987; 95(2):391-402. DOI: 10.1016/0014-4886(87)90147-6. View

12.

Browning R, Nelson D . Modification of electroshock and pentylenetetrazol seizure patterns in rats after precollicular transections. Exp Neurol. 1986; 93(3):546-56. DOI: 10.1016/0014-4886(86)90174-3. View

13.

Morimoto K, Sanei T, Sato K . Comparative study of the anticonvulsant effect of gamma-aminobutyric acid agonists in the feline kindling model of epilepsy. Epilepsia. 1993; 34(6):1123-9. DOI: 10.1111/j.1528-1157.1993.tb02144.x. View

14.

Bohlen P, Huot S, Palfreyman M . The relationship between GABA concentrations in brain and cerebrospinal fluid. Brain Res. 1979; 167(2):297-305. DOI: 10.1016/0006-8993(79)90824-2. View

15.

Loscher W, Horstermann D . Differential effects of vigabatrin, gamma-acetylenic GABA, aminooxyacetic acid, and valproate on levels of various amino acids in rat brain regions and plasma. Naunyn Schmiedebergs Arch Pharmacol. 1994; 349(3):270-8. DOI: 10.1007/BF00169293. View

16.

Racine R . Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol. 1972; 32(3):281-94. DOI: 10.1016/0013-4694(72)90177-0. View

17.

Loscher W . A comparative study of the pharmacology of inhibitors of GABA-metabolism. Naunyn Schmiedebergs Arch Pharmacol. 1980; 315(2):119-28. DOI: 10.1007/BF00499254. View

18.

Mumford J, Lewis P . Vigabatrin. Epilepsy Res Suppl. 1991; 3:161-8. View

19.

Loscher W, Jackel R, Muller F . Anticonvulsant and proconvulsant effects of inhibitors of GABA degradation in the amygdala-kindling model. Eur J Pharmacol. 1989; 163(1):1-14. DOI: 10.1016/0014-2999(89)90389-0. View

20.

Johnston G . Neuropharmacology of amino acid inhibitory transmitters. Annu Rev Pharmacol Toxicol. 1978; 18:269-89. DOI: 10.1146/annurev.pa.18.040178.001413. View